Patient randomization is nearly complete in Medicinova’s Phase 2b/3 COMBAT-ALS trial testing MN-166 (ibudilast) for the ...

The FDA had asked Sarepta to voluntarily halt all shipments of Elevidys following the deaths of three nonambulatory Duchenne ...

This study provides novel and convincing evidence that both dopamine D1 and D2 expressing neurons in the nucleus accumbens shell are crucial for the expression of cue-guided action selection, a ...

Tata Motors' shares have declined 42% from their peak, prompting analysis of whether it's a buying opportunity or a value ...

Nissan has been without an electric vehicle (EV) in its local line-up ever since stock of the outgoing Leaf hatchback dried up, but that’s soon set to change. Five years after it was initially ...

Brazil is rapidly establishing itself as a powerhouse in medical device innovation. This article shares market opportunities, ...